Home » Stocks » LNTH

Lantheus Holdings, Inc. (LNTH)

Stock Price: $18.68 USD -0.47 (-2.45%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
Market Cap 1.25B
Revenue (ttm) 339.41M
Net Income (ttm) -13.47M
Shares Out 54.13M
EPS (ttm) -0.25
PE Ratio n/a
Forward PE 83.33
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $18.68
Previous Close $19.15
Change ($) -0.47
Change (%) -2.45%
Day's Open 18.02
Day's Range 17.27 - 19.15
Day's Volume 762,494
52-Week Range 8.67 - 20.29

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 2 days ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted ther...

Business Wire - 2 weeks ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted ther...

Business Wire - 2 weeks ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 4:30 p.m. ET on Thursday, Feb...

Business Wire - 3 weeks ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (the “Company”), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a...

Business Wire - 1 month ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a glob...

Business Wire - 2 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (the Company), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a g...

Zacks Investment Research - 2 months ago

Is Lantheus Holdings (LNTH) a great pick from the value investor's perspective right now? Read on to know more.

Business Wire - 2 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., a global l...

Business Wire - 2 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (the Company), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a g...

Business Wire - 3 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a...

Business Wire - 3 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a...

Business Wire - 3 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc., and EXIN...

Business Wire - 3 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI...

Seeking Alpha - 3 months ago

Lantheus Holdings, Inc.'s (LNTH) CEO Mary Anne Heino on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 3 months ago

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 200.00% and -6.60%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for th...

Business Wire - 3 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a...

Business Wire - 3 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI...

Zacks Investment Research - 3 months ago

Lantheus Holdings (LNTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 3 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, m...

Business Wire - 4 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, Nov...

Business Wire - 4 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc., and EXIN...

Business Wire - 4 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a...

Business Wire - 5 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc.

Business Wire - 6 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc.

Seeking Alpha - 6 months ago

Lantheus Holdings, Inc.'s (LNTH) CEO Mary Anne Heino on Q2 2020 Results - Earnings Call Transcript

Business Wire - 6 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc.

Business Wire - 7 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc.

Business Wire - 7 months ago

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a...

Business Wire - 8 months ago

NORTH BILLERICA, Mass. & NEW YORK--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the...

Seeking Alpha - 9 months ago

Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q1 2020 Results - Earnings Call Transcript

Benzinga - 9 months ago

Shares of Lantheus Holdings (NASDAQ:LNTH) remained unaffected at $14.03 after the company reported Q1 results.

Seeking Alpha - 1 year ago

Lantheus Holding, Inc. (LNTH) CEO Mary Anne Heino on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Lantheus Holding Inc. (LNTH) CEO Mary Anne Heino on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 12.00% and 2.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the ...

Zacks Investment Research - 1 year ago

Lantheus Holdings (LNTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Benzinga - 1 year ago

Micro-cap biotech Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) is advancing strongly following an announcement concerning a buyout deal.

Other stocks mentioned: PGNX
The Motley Fool - 1 year ago

Shares tumble after the company announces a surprise acquisition.

GuruFocus - 1 year ago

President & CEO of Lantheus Holdings Inc (30-Year Financial, Insider Trades) Mary Anne Heino (insider trades) sold 25,538 shares of LNTH on 09/03/2019 at an average price of $21.21 a share.

Seeking Alpha - 1 year ago

Lantheus Holding Inc. (LNTH) CEO Mary Anne Heino on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 0.00% and -3.49%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 1 year ago

Lantheus Holdings (LNTH) CEO Mary Anne Heino on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 12.00% and -0.33%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

LNTH vs. CLPBY: Which Stock Is the Better Value Option?

About LNTH

Lantheus Holdings develops, manufactures, and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases worldwide. Its principal products include DEFINITY, a microbubble contrast agent used in ultrasound exams of the heart; and TechneLite, a technetium generator that provides the nuclear material used in nuclear medicine. The company also offers Xenon, a radiopharmaceutical gas used to assess pulmonary function, and to image cerebral blood flow; Neuro... [Read more...]

Industry
Diagnostics & Research
IPO Date
Jun 25, 2015
CEO
Mary Heino
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
LNTH
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for LNTH stock is "Buy." The 12-month stock price forecast is 19.80, which is an increase of 6.00% from the latest price.

Price Target
$19.80
(6.00% upside)
Analyst Consensus: Buy